Imagion Biosystems Appendix 4C - Quarterly
Imagion Biosystems has today released its Appendix 4C Quarterly Cash Flow Report and update on Company activities for the quarter ending 31 December 2019. Read…
Appointment of Vice President Clinical & Regulatory Affairs
Imagion Biosystems announces the appointment of Dr Oliver Steinbach as Vice President of Clinical and Regulatory Affairs. Read the notice.
Response to ASX price query
Imagion Biosystems has today responded to a letter sent by the ASX on 31 December 2019, noting an increase in share price and trading volume. Read the response…
Notice Pursuant to Section 708A(5)(e) of the Corporations Act
Imagion Biosystems has released "Notice Pursuant to Section 708A(5)(e) of the Corporations Act." Read the notice.
Appendix 3B
Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. Read Appendix 3B.
Change In Director's Interest Notice
Imagion Biosystems has released Change of Director's Interest Notices for David Ludvigson, Mark Van Asten, and Robert Proulx. Read the Change in Director's…
Imagion Non-Executive Director Mike Harsh tracks the history of imaging technologies
https://vimeo.com/376689656
Imagion Podcast Episode 2: Mike Harsh speaks with Marisa Zammit from WE Communications
Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion's technology could transform the imaging industry.…
Imagion Non-Executive Director Mike Harsh details how MagSense is the sixth way of imaging
https://vimeo.com/376689315
Form 604: Notice of change of interests of substantial holder
Imagion Biosystems Limited has released "Form 604: Notice of change of interests of substantial holder" to the market. Read Form 604.